A path to prediction of outcomes in juvenile idiopathic inflammatory myopathy

Ann Marie Reed, Cynthia Crowson, Jeffrey Arthur Dvergsten

Research output: Contribution to journalReview article

Abstract

Humans have an innate desire to observe and subsequently dissect an event into component pieces in an effort to better characterize the event. We then examine these pieces individually and in combinations using this information to determine the outcome of future similar events and the likelihood of their recurrence. Practically, this attempt to foretell an occurrence and predict its outcomes is evident in multiple disciplines ranging from meteorology to sociologic studies. In this manuscript we share the historical and present-day tools to predict course and outcome in juvenile idiopathic inflammatory myopathy including clinical features, testing, and biomarkers. Further we discuss considerations for building more complex predictive models of outcome especially in diseases such as juvenile idiopathic inflammatory myopathy where patients numbers are low. Many of the barriers to developing risk prediction models for juvenile idiopathic inflammatory myopathy outcomes have improved with many remaining challenges being addressed.

Original languageEnglish (US)
Article number638
JournalFrontiers in immunology
Volume10
Issue numberAPR
DOIs
StatePublished - Jan 1 2019

Fingerprint

Myositis
Meteorology
Biomarkers
Recurrence

Keywords

  • Biomarkers
  • Juvenile myositis/deratomyositis
  • Myositis
  • Outcomes
  • Predictive model

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

A path to prediction of outcomes in juvenile idiopathic inflammatory myopathy. / Reed, Ann Marie; Crowson, Cynthia; Dvergsten, Jeffrey Arthur.

In: Frontiers in immunology, Vol. 10, No. APR, 638, 01.01.2019.

Research output: Contribution to journalReview article

@article{8f2462a7a86b4fd6a7daa4961c0b97ad,
title = "A path to prediction of outcomes in juvenile idiopathic inflammatory myopathy",
abstract = "Humans have an innate desire to observe and subsequently dissect an event into component pieces in an effort to better characterize the event. We then examine these pieces individually and in combinations using this information to determine the outcome of future similar events and the likelihood of their recurrence. Practically, this attempt to foretell an occurrence and predict its outcomes is evident in multiple disciplines ranging from meteorology to sociologic studies. In this manuscript we share the historical and present-day tools to predict course and outcome in juvenile idiopathic inflammatory myopathy including clinical features, testing, and biomarkers. Further we discuss considerations for building more complex predictive models of outcome especially in diseases such as juvenile idiopathic inflammatory myopathy where patients numbers are low. Many of the barriers to developing risk prediction models for juvenile idiopathic inflammatory myopathy outcomes have improved with many remaining challenges being addressed.",
keywords = "Biomarkers, Juvenile myositis/deratomyositis, Myositis, Outcomes, Predictive model",
author = "Reed, {Ann Marie} and Cynthia Crowson and Dvergsten, {Jeffrey Arthur}",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fimmu.2019.00638",
language = "English (US)",
volume = "10",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "APR",

}

TY - JOUR

T1 - A path to prediction of outcomes in juvenile idiopathic inflammatory myopathy

AU - Reed, Ann Marie

AU - Crowson, Cynthia

AU - Dvergsten, Jeffrey Arthur

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Humans have an innate desire to observe and subsequently dissect an event into component pieces in an effort to better characterize the event. We then examine these pieces individually and in combinations using this information to determine the outcome of future similar events and the likelihood of their recurrence. Practically, this attempt to foretell an occurrence and predict its outcomes is evident in multiple disciplines ranging from meteorology to sociologic studies. In this manuscript we share the historical and present-day tools to predict course and outcome in juvenile idiopathic inflammatory myopathy including clinical features, testing, and biomarkers. Further we discuss considerations for building more complex predictive models of outcome especially in diseases such as juvenile idiopathic inflammatory myopathy where patients numbers are low. Many of the barriers to developing risk prediction models for juvenile idiopathic inflammatory myopathy outcomes have improved with many remaining challenges being addressed.

AB - Humans have an innate desire to observe and subsequently dissect an event into component pieces in an effort to better characterize the event. We then examine these pieces individually and in combinations using this information to determine the outcome of future similar events and the likelihood of their recurrence. Practically, this attempt to foretell an occurrence and predict its outcomes is evident in multiple disciplines ranging from meteorology to sociologic studies. In this manuscript we share the historical and present-day tools to predict course and outcome in juvenile idiopathic inflammatory myopathy including clinical features, testing, and biomarkers. Further we discuss considerations for building more complex predictive models of outcome especially in diseases such as juvenile idiopathic inflammatory myopathy where patients numbers are low. Many of the barriers to developing risk prediction models for juvenile idiopathic inflammatory myopathy outcomes have improved with many remaining challenges being addressed.

KW - Biomarkers

KW - Juvenile myositis/deratomyositis

KW - Myositis

KW - Outcomes

KW - Predictive model

UR - http://www.scopus.com/inward/record.url?scp=85065034957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065034957&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2019.00638

DO - 10.3389/fimmu.2019.00638

M3 - Review article

C2 - 31001260

AN - SCOPUS:85065034957

VL - 10

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - APR

M1 - 638

ER -